The Transdermal Administration of Nitrates: An Overview

Demma, Frank J.; Wilson, Richard R.
January 1983
Angiology;Jan1983, Vol. 34 Issue 1, p1
Academic Journal
Nitroglycerin has been the mainstay of the medical management of angina pectoris for over 100 years. The long-held clinical impression of the efficacy of nitroglycerin has now been clearly documented in controlled clinical trials designed to evaluate objective response to antianginal agents.'"' Advances in scientific methodology and improved experimental design have contributed to continuing interest in nitrates. Newer uses of nitroglycerin and other nitrates in congestive heart failure and acute myocardial infarction are the result of a developing understanding of the pharmacology of nitrates.


Related Articles

  • PENTRIUM THERAPY IN ANGINA PECTORIS. Dougherty, Edward S. // Angiology;Feb1965, Vol. 16 Issue 2, p57 

    1. Clinical evaluation of Pentrium, a new Librium/PETN combination, was conducted by means of a single-blind comparative study in 100 women patients with angina pectoris. 2. Employing comparable dosages, four agents�the patients' previous medication (a vasodilator), Librium alone, a...

  • Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes. Mehta, Shamir R.; Eikelboom, John W.; Demers, Catherine; Maggioni, Aldo P.; Commerford, Patrick J.; Yusuf, Salim // Canadian Journal of Physiology & Pharmacology;Jan2005, Vol. 83 Issue 1, p98 

    There are limited data regarding the incidence and clinical significance of congestive heart failure (CHF) in patients with non-ST segment elevation acute coronary syndromes (ACS). The objectives of this study were to examine the incidence, predictors, and clinical outcomes in patients with ACS...

  • counterpulsation, enhanced external.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p537 

    An encyclopedia entry for "enhanced external counterpulsation," which refers to a noninvasive treatment for angina pectoris and congestive heart failure using inflatable cuffs on the patient's legs to improve myocardial perfusion and increase cardiac output, is presented.

  • Oral nitrate preparations: An update. Bomber, Jeffrey W.; De Tullio, Pamela L. // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2331 

    Discusses various aspects of oral nitrate preparations in the United States as treatment for angina and congestive heart failure. Mechanisms of actions of oral nitrates; Preparations, dosage and administration; Dosing regimens; Pharmacokinetics; Tolerance; Adverse effects.

  • The Healthy Heart Report. Sahley, Billie J. // MMRC Health Educator Reports;2006, p1 

    The article provides information about heart diseases. A substance called homocysteine may be a factor in causing heart disease. Causes of angina pectoris, arrhythmias, atherosclerosis and congestive heart failure are discussed. Total vite, anxiety control, L-theanine and arginine are some of...

  • Nitroglycerine: Solving a Century-Old Puzzle.  // Medical Update;Jun2002, Vol. 27 Issue 12, p4 

    Presents the findings of a study conducted by researchers at Duke University Medical Center which identified the enzyme responsible for the negative effects of nitroglycerine to patients with angina.

  • Nebivolol.  // Reactions Weekly;3/9/2013, Issue 1443, p29 

    An abstract of the article "Resolution of nebivolol-induced coronary vasospasm by intracoronary nitroglycerin during a coronary angiogram," by N. I. Akkus and colleagues is presented.

  • Drug treatment of chronic stable angina pectoris.  // British Medical Journal;2/25/1978, Vol. 1 Issue 6111, p462 

    Identifies the importance of beta-adrenoceptor-blocking drugs for the management of patients with chronic stable angina pectoris. Reduction of the frequency and severity of anginal attacks; Reduction of glyceryl trinitrate consumption; Ameleoration of electrocardiographic ST segment depression;...

  • HEART SUCCESS. McCann, Jean // Drug Topics;1/1/2001, Vol. 145 Issue 1, p16 

    Reports on the drug experiment conducted on several patients for treatment of congestive heart failure. Result of the clinical trial on angiotensin II receptor blocker valsartan; Mechanism of action of the drug; Details on other treatment alternatives for angina disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics